Thursday, 2 March 2017

PTC Therapeutics' genetic disorder drug fails late-stage study

(Reuters) - PTC Therapeutics Inc said on Thursday it would stop developing its cystic fibrosis drug after it failed to meet the main goal of a late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)